PERSPECTA

News from every angle

Back to headlines

First Ozempic Generics in Canada to Challenge Novo Nordisk's Revenue

The introduction of the first Ozempic generics in Canada is expected to serve as a test case for Novo Nordisk, potentially marking the beginning of a decline in international revenue for semaglutide.

7 May, 18:39 — 7 May, 18:39
PostShare